The Egyptan International Company for Pharma Industries (EIPICO) will start production on its third plant in May, thelocal press reports. The factory, based in the Tenth of Ramadan City, cost EIPICO EGP 1 bn and is expected to contribute to the government’s fight against the covid-19 outbreak by producing genetically modified proteins.
More from Enterprise
Your points are currency, treat them like one
Most people treat credit card points like a pleasant surprise:…
How should young people think about money and budgeting?
Your income and your time are your biggest assets in…
Why the EGX30 futures market hasn’t taken off yet
EGX30 index futures are averaging a handful of trades a…
Blnk raises USD 37.1 mn to scale its consumer finance operations
The local fintech reached profitability last year and will use…